Increased Gastric Cancer Risk with PTEN IVS4 Polymorphism in a Turkish Population

Abstract

We aimed to investigate the association of the phosphatase and tensin homolog (PTEN) IVS4 polymorphism with a gastric cancer (GC) risk in the Turkish population. A hospital-based case-control study was conducted in 93 patients with GC, and 113 healthy controls. The PTEN IVS4 (rs no: 3830675) polymorphism was determined by using polymerase chain reaction-restriction fragment length polymorphism analysis. The PTEN IVS4 (−/−) genotype exhibited a significantly elevated risk for GC compared to controls (p<0.005; odds ratio: 1.6, 95% confidence interval: 1.19-2.14). Analyses on clinicopathological parameters showed that PTEN IVS4 genotypes were not associated with any of the variables of patients with GC (p>0.05). In conclusion, the PTEN IVS4 polymorphism might contribute to the development of GC in a Turkish population. Further studies, including comparison of the PTEN IVS4 polymorphism with plasma and tissue expressions of PTEN in larger study size groups will provide a further assessment of the PTEN IVS4 polymorphism in GC patients.

Get full access to this article

View all access options for this article.

References

Carroll

, Couch

, Rebbeck

, Weber

. 1999. Polymorphisms in PTEN in breast cancer families. J Med Genet, 36:94-96.

, Cao

, Cgen

et al. 2008. Pten polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in high incidence region of China. Dis Esophagus, 21:409-415.

George

, Shepard

, Ma

et al. 2001. PTEN polymorphism (IVS4) is not associated with risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 10:411-412.

Guo

, Xu

, Wu

, Liu

. 2008. PCR-SSCP-DNA sequencing method detecting PTEN gene mutation and its significance in human gastric cancer. Worl J Gastroenterol, 14:3804-3811.

Jemal

, Center

, DeSantis

, Ward

. 2010. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19:1893-1907.

Jiang

, Fan

, Jiang

et al. 2003. Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma. World J Gastroenterol, 9:491-494.

, Yen

, Liaw

et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275:1943-1947.

Lynch

, Smyrk

, Watson

et al. 1993. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology, 104:1535-1549.

Marsh

, Coulon

, Lunetta

et al. 1998. Mutation spectrum and genotype-fenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet, 7:507-515.

10.

Miller

, Dykes

, Polesky

. 1988. Simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res, 16:1215.

11.

Milne

, Carneiro

, O'morain

, Offerhaus

. 2009. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet, 126:615-28.

12.

Okami

, Wu

, Riggins

et al. 1998. Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res, 58:509-511.

13.

Resende

, Ristimaki

, Machado

. 2010. Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter, 15:34-39.

14.

Sato

, Tamura

, Tsuchiya

et al. 2002. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch, 440:160-165.

15.

Vogiatzi

, Vindigni

, Roviello

et al. 2007. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Phsiol, 211:287-295.

16.

Wang

, Huan

, Chen

et al. 2003. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch, 442:437-443.

17.

Wen

, Wang

, Zhou

et al. 2010. Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway. Oncol Reports, 24:89-95.

18.

, Senechal

, Neshat

et al. 1998. The PTEN/MMAC1 tumor suppressor phosphotase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A, 95:1558-15591.

19.

Yin

, Hu

, Tan

et al. 2009. Molecular epidemiology of genetic susceptibility to gastric cancer: facus on single nucleotide polymorphisms in gastric carcinogenesis. Am J Transl Res, 1:44-54.